Dysport vs Botox: Understanding the Difference Between Toxin Brands

Practitioners are frequently asked which botulinum toxin brand is "better" — Dysport or Botox. The honest answer is that it depends on training, technique, and patient factors more than any inherent superiority of one product over the other. What matters more in day-to-day practice is understanding that the two are not simply interchangeable at a one-to-one ratio, and why. This overview is educational and does not provide dosing or reconstitution instructions; always follow the specific manufacturer's current product information.

Two Products, Two Manufacturers

Botox is manufactured by Allergan and was the first botulinum toxin product to achieve widespread cosmetic recognition, to the point that its brand name is often used informally as a catch-all term for the category. Dysport is manufactured by Ipsen Biopharm and has built its own substantial market presence, particularly for larger treatment areas where its diffusion characteristics are often considered favourable. Both are formulations of botulinum toxin type A, and both work through the same fundamental mechanism: temporarily interrupting the nerve signal that triggers muscle contraction.

Why the Two Are Not Directly Interchangeable

The critical distinction practitioners need to hold onto is that Botox and Dysport are measured in different, brand-specific unit systems. A "unit" of Botox is not equivalent to a "unit" of Dysport, and the conversion ratio between the two is not a simple one-to-one substitution. This is a genuinely common source of confusion, particularly for practitioners newer to working across brands, and it is also one of the more consequential ones — treating a Dysport unit as though it were a Botox unit, or vice versa, would lead to a significantly under- or over-dosed treatment.

Because unit systems, reconstitution guidance, and recommended dilution volumes differ by manufacturer and are subject to updates in product labelling, practitioners should always work directly from the current manufacturer's instructions for the specific product in hand, rather than relying on a remembered ratio or a figure seen in general reading — including this article.

Other Practical Differences

Beyond the unit conversion issue, a handful of other differences shape how practitioners choose between the two. Diffusion characteristics are commonly discussed as differing between the products, which can influence brand choice depending on the treatment area and the precision required. Neither product's standard formulation includes lidocaine, which means patient comfort during treatment relies on technique and, where appropriate, a topical anaesthetic applied beforehand rather than an anaesthetic built into the toxin solution itself.

Onset and duration are broadly comparable between the two brands in most published comparisons, though individual practitioner experience and patient-reported outcomes can vary, and neither product should be assumed to outperform the other as a blanket rule.

Storage and Handling

Both products require careful cold-chain handling from manufacturer to patient, and both are supplied as a vacuum-dried or lyophilised powder requiring reconstitution before use — the specifics of which, again, sit with each manufacturer's current instructions rather than general reading. Once reconstituted, both have a limited window in which they should be used, after which efficacy cannot be guaranteed. Clinics working with both brands should keep clearly separated, well-labelled storage to avoid any risk of confusing product, vial size, or reconstitution guidance between them — a straightforward precaution that prevents a genuinely serious dosing error.

Choosing Between Them in Practice

In practice, many experienced practitioners work confidently with either product, and the choice often comes down to training background, familiarity, patient preference, and the specific treatment area under consideration. What should not vary is diligence around product-specific documentation: reconstitution guidance, storage requirements, and unit-dosing information belong to the manufacturer's current instructions for use, checked at the time of every treatment rather than recalled from memory or an earlier training session.

The Takeaway

Dysport and Botox are both well-established botulinum toxin type A products working through the same underlying mechanism, but their different unit systems mean they are not interchangeable without careful reference to manufacturer guidance. The safest approach for any practitioner working across brands is to treat each product's documentation as the authority, every time.

For the needles, syringes, and injection consumables that support toxin treatments regardless of brand, browse the needles and syringes range.